EyePoint Pharmaceuticals taps new president

EyePoint Pharmaceuticals has tapped its COO, Jay Duker, MD, as its next president. 

Advertisement

Dr. Duker has served as the company’s chief operating officer since November 2021 and will stay in his current role in addition to taking on presidential responsibilities, according to a Jan. 4 news release from EyePoint. He will also be responsible for monitoring regulatory affairs. 

Dr. Duker has previously held roles at the New England Eye Center and the Tufts University School of Medicine in Boston. 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.